Surveillance To Track Progress Toward Poliomyelitis Eradication - Worldwide, 2021-2022.
Journal
MMWR. Morbidity and mortality weekly report
ISSN: 1545-861X
Titre abrégé: MMWR Morb Mortal Wkly Rep
Pays: United States
ID NLM: 7802429
Informations de publication
Date de publication:
09 Jun 2023
09 Jun 2023
Historique:
medline:
12
6
2023
pubmed:
8
6
2023
entrez:
8
6
2023
Statut:
epublish
Résumé
Since the Global Polio Eradication Initiative (GPEI) was established in 1988, the number of wild poliovirus (WPV) cases has declined by >99.9%, and WPV serotypes 2 and 3 have been declared eradicated (1). By the end of 2022, WPV type 1 (WPV1) transmission remained endemic only in Afghanistan and Pakistan (2,3). However, during 2021-2022, Malawi and Mozambique reported nine WPV1 cases that were genetically linked to Pakistan (4,5), and circulating vaccine-derived poliovirus (cVDPV) outbreaks were detected in 42 countries (6). cVDPVs are oral poliovirus vaccine-derived viruses that can emerge after prolonged circulation in populations with low immunity allowing reversion to neurovirulence and can cause paralysis. Polioviruses are detected primarily through surveillance for acute flaccid paralysis (AFP), and poliovirus is confirmed through stool specimen testing. Environmental surveillance, the systematic sampling of sewage and testing for the presence of poliovirus, supplements AFP surveillance. Both surveillance systems were affected by the COVID-19 pandemic's effects on public health activities during 2020 (7,8) but improved in 2021 (9). This report updates previous reports (7,9) to describe surveillance performance during 2021-2022 in 34 priority countries.* In 2022, a total of 26 (76.5%) priority countries met the two key AFP surveillance performance indicator targets nationally compared with 24 (70.6%) countries in 2021; however, substantial gaps remain in subnational areas. Environmental surveillance expanded to 725 sites in priority countries, a 31.1% increase from the 553 sites reported in 2021. High-quality surveillance is critical to rapidly detect poliovirus transmission and enable prompt poliovirus outbreak response to stop circulation. Frequent monitoring of surveillance guides improvements to achieve progress toward polio eradication.
Identifiants
pubmed: 37289657
doi: 10.15585/mmwr.mm7223a1
pmc: PMC10328463
doi:
Substances chimiques
alpha-Fetoproteins
0
Poliovirus Vaccine, Oral
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
613-620Déclaration de conflit d'intérêts
All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.
Références
MMWR Morb Mortal Wkly Rep. 2022 May 13;71(19):650-655
pubmed: 35552352
MMWR Morb Mortal Wkly Rep. 2021 May 07;70(18):667-673
pubmed: 33956779
J Infect Dis. 2017 Jul 1;216(suppl_1):S299-S307
pubmed: 28838192
MMWR Morb Mortal Wkly Rep. 2023 Apr 07;72(14):366-371
pubmed: 37022974
MMWR Morb Mortal Wkly Rep. 2021 Jan 01;69(5152):1648-1652
pubmed: 33382673
MMWR Morb Mortal Wkly Rep. 2022 Apr 15;71(15):538-544
pubmed: 35421079
MMWR Morb Mortal Wkly Rep. 2022 Dec 09;71(49):1541-1546
pubmed: 36480464
MMWR Morb Mortal Wkly Rep. 2022 Oct 21;71(42):1313-1318
pubmed: 36264783